OxyPure (olifilcon A) Spherical Biweekly Silicone Hydrogel Soft Contact Lens; OxyPure (olifilcon A) Toric Biweekly Silicone Hydrogel Soft Contact Lens; OxyPure (olifilcon A) Multifocal Biweekly Silicone Hydrogel Soft Contact Lens
Visco Vision, Inc. · Decision date Oct 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-23 for K253875, a traditional 510(k) from Visco Vision, Inc. of Taoyuan City, TW. The device is listed as OxyPure (olifilcon A) biweekly silicone hydrogel soft contact lenses in spherical, toric and multifocal designs, classified as Lenses, Soft Contact, Daily Wear under 21 CFR 886.5925, product code LPL with subsequent product code MVN, in the Ophthalmic specialty. The application was received 12/04/2025 and was not reviewed by a third party.
SESE means FDA cleared the submission as substantially equivalent to a predicate device; it is not PMA approval. The record does not identify the predicate device, the specific tests or clinical data supporting equivalence, or any labeling conditions, so the basis for the equivalence finding remains unknown from this source. No summary statement is attached to the record, and the page shows no combination product or predetermined change control plan.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253875
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Visco Vision, Inc.
- Product code
- LPL
- Decision code
- SESE
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lenses, Soft Contact, Daily Wear.
- Applicant
- Visco Vision, Inc.
- Product code
- LPL
- FDA device class
- 2
FDA decision timeline
K253875 received
Application receipt date recorded by FDA.
K253875 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LPL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| St. shine Optical Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Bausch + Lomb, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Menicon Co, Ltd. | 510(k) clearance | Sep 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Visco Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Taoyuan City
Sources and methodology
- Original FDA record: K253875
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

